Clinical Trial Update: The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating non-steroidal anti-inflammatory drugs for benign prostatic hyperplasia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Non-steroidal anti-inflammatory drugs

Snippet

Sponsor: Samsung Medical Center | Conditions: Benign Prostatic Hyperplasia | Phase 4 | Status: WITHDRAWN